TNF Pharmaceuticals, Inc.
TNF Pharmaceuticals, Inc.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Isomyosamine in Reducing Inflammation and Treating Muscle Loss in Older Adults After Hip or Thigh Bone Fractures | Atrophy, Femoral Fractures, Frailty, Hip Injuries, Leg Injuries, Neurologic Manifestations, Neuromuscular Manifestations, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, bone fracture, hip fracture, injury, muscular atrophy, nervous system disorder | Not yet recruiting | Phase 2 | 2025-04-24 | NCT06942182 |